Stockpickr: The Top Dividend 'Aristocrats'

Stock quotes in this article: ADP , SIAL , WAG , MGM , DTV  

Another company that has increased dividends for the past 25 years and is cheap relative to its historical valuation right now is Sigma-Aldrich(SIAL Quote). The company makes and distributes chemicals and kits for genomic research, biotech research and pharmaceutical development.

Sigma-Aldrich offers an excellent, indirect way to play the aging baby boomer trend. Because of the size of that generation, you can expect more research, more drugs and more development in the biotech/pharma space over the next 50 years.

Sigma-Aldrich has a rock-solid balance sheet with $173 million in cash, about $500 million of debt, but with $509 million in EBITDA and growing. Again, at 11 times cash flows, the only thing that worries me is that the company can get acquired too quickly to enjoy the next 25 years of dividend increases.

Sigma-Aldrich is also listed in the Claymore/Sabrient Insider ETF, an exchange-traded fund that tracks companies where there's been heavy insider buying and analysts recently have increased estimates.

In fact, about 90 days ago, analysts had expected, on average, Sigma-Aldrich to hit $2.15 in EPS for 2007. Now they expect $2.20. And recently, several officers of the company have bought Sigma-Aldrich shares on the open market. Other stocks on the Claymore/Sabrient Insider ETF include MGM Mirage(MGM Quote) and DirecTV(DTV Quote).

One of Jim Cramer's favorites on the Aristocrats list is drugstore chain Walgreen(WAG Quote). For the past 20 years, Wal-Mart has haunted Walgreen investors. There's always the fear that Wal-Mart can infringe on Walgreen's business.

That said, however, Walgreen has a lot of cushion, with about $1 billion cash in the bank, no debt and EBITDA of $3.8 billion on an enterprise value of $45 billion, giving it an enterprise value over EBITDA of just 12.

Walgreen's 22-year chart offers a not-so-bad picture either:


Walgreen (WAG)

Here are some of my other favorite dividend portfolios:

  • Loading Comments...
  •  
1 2
Next >

SHARE:

  • email
  • print
  • comment
  • digg
  • delicious
  • linkedin
At the time of publication, Altucher and/or his fund had no positions in stocks mentioned, although positions may change at any time.

James Altucher is a managing partner at Formula Capital, an alternative asset management firm that runs several quantitative-based hedge funds as well as a fund of hedge funds. He is also the author of Trade Like a Hedge Fund and Trade Like Warren Buffett. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Altucher appreciates your feedback; click here to send him an email.

TheStreet.com has a revenue-sharing relationship with Trader's Library under which it receives a portion of the revenue from purchases by customers directed there from TheStreet.com.

Recent Comments





Connect with TheStreet

Dow Jones S&P 500 NASDAQ 10-Year Note
10,405.83 1,102.35 2,190.86 34.82
Oil *
71.97
UP
68.78
UP
6.41
UP
7.13
UP
0.59
10 Yr
3.48%
SPDR Gold
110.82
+0.67%
+0.58%
+0.33%
+1.72%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services